IL22 and asthma: Five endotypes were identified; three were severe asthma endotypes: two were associated with sputum neutrophilia with one linked predominantly with Moraxella catarrhalis and to a lesser extent Haemophillus influenzae, while the other with a drug response signature to anti‐IL‐22 antibody treatment, and the third one with sputum eosinophilia.